Jonas Kingo: ISTH 2026 in Paris Brings the Global Hemostasis Community Together
Jonas Kingo, CEO at Aniara Holding, shared a post on LinkedIn:
“22 days to ISTH 2026 in Paris.
We’re in the final stretch of preparation — and the excitement in the hemostasis community is real.
3,188 abstracts accepted. 6,000+ attendees expected from over 100 countries.
The full abstract book drops June 26 — one week from today.
For our team, ISTH is the highlight of the year.
It’s where the science we work with every day gets presented, debated, and advanced.
It’s where researchers and lab directors we’ve known for years compare notes in person.
And it’s where the next generation of hemostasis scientists present their first major work.
Aniara will be at Paris Expo Porte de Versailles, Pavilion 7, representing HYPHEN BioMed, 5-Diagnostics, Medicago, and Xenometrix.
If you’re going to Paris and haven’t connected with us yet — now is the time.
Our schedule fills up fast once we land.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge